Previous close | 142.74 |
Open | 143.56 |
Bid | 164.10 |
Ask | 170.60 |
Strike | 250.00 |
Expiry date | 2025-01-17 |
Day's range | 141.99 - 143.56 |
Contract range | N/A |
Volume | |
Open interest | N/A |
The FDA approved Moderna's RSV vaccine, allowing the biotech to launch its second-ever product. But Moderna stock retreated.
Moderna stock is on the rise again as investors focus on the potential need for a bird flu vaccine. Is MRNA stock a buy right now?
Moderna stock seesawed Thursday after confirming the U.S. government is nearing a deal to fund its pandemic bird flu vaccine.